Skip to main content
Top
Published in: Diabetologia 2/2014

01-02-2014 | Article

The role of the transcription factor ETV5 in insulin exocytosis

Authors: Ruth Gutierrez-Aguilar, Dong-Hoon Kim, Marina Casimir, Xiao-Qing Dai, Paul T. Pfluger, Jongsun Park, April Haller, Elizabeth Donelan, Jisoo Park, David D’Alessio, Stephen C. Woods, Patrick E. MacDonald, Randy J. Seeley

Published in: Diabetologia | Issue 2/2014

Login to get access

Abstract

Aims/hypothesis

Genome-wide association studies have revealed an association of the transcription factor ETS variant gene 5 (ETV5) with human obesity. However, its role in glucose homeostasis and energy balance is unknown.

Methods

Etv5 knockout (KO) mice were monitored weekly for body weight (BW) and food intake. Body composition was measured at 8 and 16 weeks of age. Glucose metabolism was studied, and glucose-stimulated insulin secretion was measured in vivo and in vitro.

Results

Etv5 KO mice are smaller and leaner, and have a reduced BW and lower fat mass than their wild-type controls on a chow diet. When exposed to a high-fat diet, KO mice are resistant to diet-induced BW gain. Despite a greater insulin sensitivity, KO mice have profoundly impaired glucose tolerance associated with impaired insulin secretion. Morphometric analysis revealed smaller islets and a reduced beta cell size in the pancreatic islets of Etv5 KO mice. Knockdown of ETV5 in an insulin-secreting cell line or beta cells from human donors revealed intact mitochondrial and Ca2+ channel activity, but reduced insulin exocytosis.

Conclusion/interpretation

This work reveals a critical role for ETV5 in specifically regulating insulin secretion both in vitro and in vivo.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hollenhorst PC, McIntosh LP, Graves BJ (2011) Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem 80:437–471PubMedCrossRef Hollenhorst PC, McIntosh LP, Graves BJ (2011) Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem 80:437–471PubMedCrossRef
2.
go back to reference Galang CK, Muller WJ, Foos G, Oshima RG, Hauser CA (2004) Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors. J Biol Chem 279:11281–11292PubMedCrossRef Galang CK, Muller WJ, Foos G, Oshima RG, Hauser CA (2004) Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors. J Biol Chem 279:11281–11292PubMedCrossRef
3.
go back to reference Sementchenko VI, Watson DK (2000) Ets target genes: past, present and future. Oncogene 19:6533–6548PubMedCrossRef Sementchenko VI, Watson DK (2000) Ets target genes: past, present and future. Oncogene 19:6533–6548PubMedCrossRef
4.
5.
go back to reference Gutierrez-Hartmann A, Duval DL, Bradford AP (2007) ETS transcription factors in endocrine systems. Trends Endocrinol Metab 18:150–158PubMedCrossRef Gutierrez-Hartmann A, Duval DL, Bradford AP (2007) ETS transcription factors in endocrine systems. Trends Endocrinol Metab 18:150–158PubMedCrossRef
6.
go back to reference Kobberup S, Nyeng P, Juhl K, Hutton J, Jensen J (2007) ETS-family genes in pancreatic development. Dev Dyn 236:3100–3110PubMedCrossRef Kobberup S, Nyeng P, Juhl K, Hutton J, Jensen J (2007) ETS-family genes in pancreatic development. Dev Dyn 236:3100–3110PubMedCrossRef
7.
go back to reference Kobberup S, Schmerr M, Dang ML et al (2010) Conditional control of the differentiation competence of pancreatic endocrine and ductal cells by Fgf10. Mech Dev 127:220–234PubMedCentralPubMedCrossRef Kobberup S, Schmerr M, Dang ML et al (2010) Conditional control of the differentiation competence of pancreatic endocrine and ductal cells by Fgf10. Mech Dev 127:220–234PubMedCentralPubMedCrossRef
8.
go back to reference Norgaard GA, Jensen JN, Jensen J (2003) FGF10 signaling maintains the pancreatic progenitor cell state revealing a novel role of Notch in organ development. Dev Biol 264:323–338PubMedCrossRef Norgaard GA, Jensen JN, Jensen J (2003) FGF10 signaling maintains the pancreatic progenitor cell state revealing a novel role of Notch in organ development. Dev Biol 264:323–338PubMedCrossRef
9.
go back to reference Thorleifsson G, Walters GB, Gudbjartsson DF et al (2009) Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 41:18–24PubMedCrossRef Thorleifsson G, Walters GB, Gudbjartsson DF et al (2009) Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 41:18–24PubMedCrossRef
10.
go back to reference Willer CJ, Speliotes EK, Loos RJ et al (2009) Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 41:25–34PubMedCentralPubMedCrossRef Willer CJ, Speliotes EK, Loos RJ et al (2009) Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 41:25–34PubMedCentralPubMedCrossRef
11.
12.
go back to reference Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB (2000) Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 49:424–430PubMedCrossRef Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB (2000) Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 49:424–430PubMedCrossRef
13.
go back to reference Dai XQ, Plummer G, Casimir M et al (2011) SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans. Diabetes 60:838–847PubMedCrossRef Dai XQ, Plummer G, Casimir M et al (2011) SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans. Diabetes 60:838–847PubMedCrossRef
14.
go back to reference Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschop MH (2008) Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A 105:9793–9798PubMedCentralPubMedCrossRef Pfluger PT, Herranz D, Velasco-Miguel S, Serrano M, Tschop MH (2008) Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A 105:9793–9798PubMedCentralPubMedCrossRef
15.
go back to reference Hippenmeyer S, Huber RM, Ladle DR, Murphy K, Arber S (2007) ETS transcription factor Erm controls subsynaptic gene expression in skeletal muscles. Neuron 55:726–740PubMedCrossRef Hippenmeyer S, Huber RM, Ladle DR, Murphy K, Arber S (2007) ETS transcription factor Erm controls subsynaptic gene expression in skeletal muscles. Neuron 55:726–740PubMedCrossRef
16.
go back to reference Schlesser HN, Simon L, Hofmann MC et al (2008) Effects of ETV5 (ets variant gene 5) on testis and body growth, time course of spermatogonial stem cell loss, and fertility in mice. Biol Reprod 78:483–489PubMedCentralPubMedCrossRef Schlesser HN, Simon L, Hofmann MC et al (2008) Effects of ETV5 (ets variant gene 5) on testis and body growth, time course of spermatogonial stem cell loss, and fertility in mice. Biol Reprod 78:483–489PubMedCentralPubMedCrossRef
17.
go back to reference Liu Y, Jiang H, Crawford HC, Hogan BL (2003) Role for ETS domain transcription factors Pea3/Erm in mouse lung development. Dev Biol 261:10–24PubMedCrossRef Liu Y, Jiang H, Crawford HC, Hogan BL (2003) Role for ETS domain transcription factors Pea3/Erm in mouse lung development. Dev Biol 261:10–24PubMedCrossRef
18.
go back to reference Lu BC, Cebrian C, Chi X et al (2009) Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis. Nat Genet 41:1295–1302PubMedCentralPubMedCrossRef Lu BC, Cebrian C, Chi X et al (2009) Etv4 and Etv5 are required downstream of GDNF and Ret for kidney branching morphogenesis. Nat Genet 41:1295–1302PubMedCentralPubMedCrossRef
19.
go back to reference Brent AE, Tabin CJ (2004) FGF acts directly on the somitic tendon progenitors through the Ets transcription factors Pea3 and Erm to regulate scleraxis expression. Development 131:3885–3896PubMedCrossRef Brent AE, Tabin CJ (2004) FGF acts directly on the somitic tendon progenitors through the Ets transcription factors Pea3 and Erm to regulate scleraxis expression. Development 131:3885–3896PubMedCrossRef
20.
go back to reference Ishii K, Kanatsu-Shinohara M, Toyokuni S, Shinohara T (2012) FGF2 mediates mouse spermatogonial stem cell self-renewal via upregulation of Etv5 and Bcl6b through MAP2K1 activation. Development 139:1734–1743PubMedCrossRef Ishii K, Kanatsu-Shinohara M, Toyokuni S, Shinohara T (2012) FGF2 mediates mouse spermatogonial stem cell self-renewal via upregulation of Etv5 and Bcl6b through MAP2K1 activation. Development 139:1734–1743PubMedCrossRef
21.
go back to reference Kayali AG, Stotland A, Gunst KV et al (2005) Growth factor-induced signaling of the pancreatic epithelium. J Endocrinol 185:45–56PubMedCrossRef Kayali AG, Stotland A, Gunst KV et al (2005) Growth factor-induced signaling of the pancreatic epithelium. J Endocrinol 185:45–56PubMedCrossRef
22.
go back to reference Janknecht R, Monte D, Baert JL, de Launoit Y (1996) The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA. Oncogene 13:1745–1754PubMed Janknecht R, Monte D, Baert JL, de Launoit Y (1996) The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA. Oncogene 13:1745–1754PubMed
23.
go back to reference Giordano E, Cirulli V, Bosco D, Rouiller D, Halban P, Meda P (1993) B cell size influences glucose-stimulated insulin secretion. Am J Physiol 265:C358–C364PubMed Giordano E, Cirulli V, Bosco D, Rouiller D, Halban P, Meda P (1993) B cell size influences glucose-stimulated insulin secretion. Am J Physiol 265:C358–C364PubMed
24.
go back to reference Eliasson L, Abdulkader F, Braun M, Galvanovskis J, Hoppa MB, Rorsman P (2008) Novel aspects of the molecular mechanisms controlling insulin secretion. J Physiol 586:3313–3324PubMedCrossRef Eliasson L, Abdulkader F, Braun M, Galvanovskis J, Hoppa MB, Rorsman P (2008) Novel aspects of the molecular mechanisms controlling insulin secretion. J Physiol 586:3313–3324PubMedCrossRef
25.
26.
go back to reference Gerber SH, Sudhof TC (2002) Molecular determinants of regulated exocytosis. Diabetes 51(Suppl 1):S3–S11PubMedCrossRef Gerber SH, Sudhof TC (2002) Molecular determinants of regulated exocytosis. Diabetes 51(Suppl 1):S3–S11PubMedCrossRef
27.
go back to reference Gauthier BR, Wollheim CB (2008) Synaptotagmins bind calcium to release insulin. Am J Physiol Endocrinol Metab 295:E1279–E1286PubMedCrossRef Gauthier BR, Wollheim CB (2008) Synaptotagmins bind calcium to release insulin. Am J Physiol Endocrinol Metab 295:E1279–E1286PubMedCrossRef
28.
go back to reference Washbourne P, Thompson PM, Carta M et al (2002) Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Nat Neurosci 5:19–26PubMed Washbourne P, Thompson PM, Carta M et al (2002) Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Nat Neurosci 5:19–26PubMed
29.
go back to reference Jeans AF, Oliver PL, Johnson R et al (2007) A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse. Proc Natl Acad Sci U S A 104:2431–2436PubMedCentralPubMedCrossRef Jeans AF, Oliver PL, Johnson R et al (2007) A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse. Proc Natl Acad Sci U S A 104:2431–2436PubMedCentralPubMedCrossRef
30.
go back to reference Boal F, Laguerre M, Milochau A, Lang J, Scotti PA (2011) A charged prominence in the linker domain of the cysteine-string protein Cspalpha mediates its regulated interaction with the calcium sensor synaptotagmin 9 during exocytosis. FASEB J 25:132–143PubMedCrossRef Boal F, Laguerre M, Milochau A, Lang J, Scotti PA (2011) A charged prominence in the linker domain of the cysteine-string protein Cspalpha mediates its regulated interaction with the calcium sensor synaptotagmin 9 during exocytosis. FASEB J 25:132–143PubMedCrossRef
31.
go back to reference Speliotes EK, Willer CJ, Berndt SI et al (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42:937–948PubMedCentralPubMedCrossRef Speliotes EK, Willer CJ, Berndt SI et al (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 42:937–948PubMedCentralPubMedCrossRef
Metadata
Title
The role of the transcription factor ETV5 in insulin exocytosis
Authors
Ruth Gutierrez-Aguilar
Dong-Hoon Kim
Marina Casimir
Xiao-Qing Dai
Paul T. Pfluger
Jongsun Park
April Haller
Elizabeth Donelan
Jisoo Park
David D’Alessio
Stephen C. Woods
Patrick E. MacDonald
Randy J. Seeley
Publication date
01-02-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 2/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3096-5

Other articles of this Issue 2/2014

Diabetologia 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.